Adrenomedullin and Outcome in Severe Sepsis and Septic Shock

CompletedOBSERVATIONAL
Enrollment

596

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Severe SepsisSeptic Shock
Trial Locations (24)

1200

Cliniques Universitaires Saint-Luc, Brussels

1340

Clinique St Pierre, Ottignies

6525

UMC Radboudziekenhuis, Dept. Intensive Care, Nijmegen

7100

CH Jolimont, La Louvière

16959

Centre Hospitalier d'Angoulême, Angoulême

37044

CHRU Tours, Tours

49933

Centre Hospitalier d'Angers, Angers

50937

Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Köln, Cologne

63003

Hopital Estaing, Clermont-Ferrand

67000

Nouvel Hôpital Civil, Strasbourg

67098

Hôpital de Hautepierre, Strasbourg

75010

Hôpital St Louis, Paris

75018

Hôpital Bichat Claude-Bernard, Paris

85000

CHD de la Vendée, La Roche-sur-Yon

86156

Klinikum Augsburg, Augsburg

87042

CHU Dupuytren, Limoges

92700

Hôpital Louis Mourier,, Colombes

Unknown

Hôpital Lariboisière, Paris

Klinik für Operative Intensivmedizin und Intermediate Care, Aachen

Azienda Ospedaliera Sant'Andrea, Roma

Policlinico Universitario A. Gemelli, Roma

D99089

Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, HELIOS-Klinikum Erfurt,, Erfurt

07740

Universitätsklinikum Jena, Jena

7513 ER

Medisch Spectrum Twente; Departement of Intensive Care, Enschede

All Listed Sponsors
collaborator

Fondation Transplantation_EDDH

UNKNOWN

collaborator

Hopital Lariboisière

OTHER

collaborator

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

lead

Sphingotec GmbH

INDUSTRY

NCT02393781 - Adrenomedullin and Outcome in Severe Sepsis and Septic Shock | Biotech Hunter | Biotech Hunter